CA3256233A1 - Anticorps dirigé contre c-met et son utilisation - Google Patents

Anticorps dirigé contre c-met et son utilisation

Info

Publication number
CA3256233A1
CA3256233A1 CA3256233A CA3256233A CA3256233A1 CA 3256233 A1 CA3256233 A1 CA 3256233A1 CA 3256233 A CA3256233 A CA 3256233A CA 3256233 A CA3256233 A CA 3256233A CA 3256233 A1 CA3256233 A1 CA 3256233A1
Authority
CA
Canada
Prior art keywords
seq
set forth
antibody
sequence
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3256233A
Other languages
English (en)
Inventor
Fan Wu
Xiaoniu MIAO
Yi Luo
Ping Wang
Zhenting ZHAO
Original Assignee
Biotheus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotheus Inc filed Critical Biotheus Inc
Publication of CA3256233A1 publication Critical patent/CA3256233A1/fr
Pending legal-status Critical Current

Links

CA3256233A 2022-04-02 2023-03-31 Anticorps dirigé contre c-met et son utilisation Pending CA3256233A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210345737.1 2022-04-02

Publications (1)

Publication Number Publication Date
CA3256233A1 true CA3256233A1 (fr) 2025-06-21

Family

ID=

Similar Documents

Publication Publication Date Title
US20220363781A1 (en) Anti-tslp antibody and uses thereof
US20250223366A1 (en) Monoclonal antibodies and bispecific antibody against c-met
EP4039704A1 (fr) Anticorps anti-pd-1 et son utilisation
KR20240049318A (ko) Fap/cd40 결합 분자 및 이의 의학적 용도
JP7352007B2 (ja) ヒト化抗ｖｅｇｆモノクローナル抗体
KR20250057832A (ko) 갑상선 자극 호르몬 수용체에 결합하는 항체 및 이의 용도
JP2025505650A5 (fr)
EP4613766A1 (fr) Anticorps anti-ccr8 et son utilisation
EP4592321A1 (fr) Anticorps anti-her2 et leur utilisation
JP2022550121A (ja) Ｌｉｆに特異的な結合分子及びその使用
US20260028417A1 (en) Her3 binding protein and use thereof
EP4506361A1 (fr) Anticorps dirigé contre c-met et son utilisation
CA3256233A1 (fr) Anticorps dirigé contre c-met et son utilisation
TW202442686A (zh) 針對c-Met的抗體及其用途
CA3255773A1 (fr) Anticorps monoclonal et anticorps bispécifique dirigés contre c-met
CN118598997A (zh) 抗b7-h3抗体及其抗肿瘤应用
WO2025082429A1 (fr) Anticorps bispécifique dirigé contre ccr8 et ctla4
TW202442687A (zh) 針對c-met的單植株抗體以及雙特異性抗體
KR20250075621A (ko) 항체 및 종양 저항에서의 이의 용도
WO2026017189A2 (fr) Anticorps anti-il-31, composition pharmaceutique associée et utilisation associée
WO2025124443A1 (fr) Protéine de liaison à adam9 et son utilisation
CN117417447A (zh) 特异性结合igf1r的抗体及其应用
CN121873241A (zh) 抗pacap抗体及其应用
CA3133163A1 (fr) Liants proteiques pour irhom2